1-5 of 5
Ted A. Gooley
Close
Sort by
Journal Articles

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

Clinical Trials & Observations
Chaitra Ujjani, Ted A. Gooley, Stephen E. Spurgeon, Deborah M. Stephens, Catherine Lai, Catherine M. Broome, Susan O’Brien, Haiying Zhu, Kerry J. Laing, Allison M. Winter, Georgios Pongas, Alexander L Greninger, David M. Koelle, Tanya Siddiqi, Matthew S. Davids, Kerry A. Rogers, Alexey V. Danilov, Amy Sperling, Brian Tu, Tyler Sorensen, Kelsey Launchbury, Carlissa J. Burrow, Genesis Quezada, Joshua A. Hill, Mazyar Shadman, Philip A. Thompson
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4728–4737.
https://doi.org/10.1182/bloodadvances.2022009164
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation

Masumi Ueda Oshima, Hu Xie, Danniel Zamora, Mary E. Flowers, Geoffrey R. Hill, Marco B. Mielcarek, Brenda M. Sandmaier, Ted A. Gooley, Michael J. Boeckh
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1394–1403.
https://doi.org/10.1182/bloodadvances.2022009112
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

Clinical Trials & Observations
Solomon A. Graf, Ryan C. Lynch, Chaitra S. Ujjani, Ted A. Gooley, Heather Rasmussen, David G. Coffey, Andrew J. Cowan, Stephen D. Smith, Mazyar Shadman, Edus H. Warren, Edward N. Libby, III, Alexander L. Greninger, Jonathan R. Fromm, Ajay K. Gopal
Journal: Blood Advances
Blood Adv (2023) 7 (5): 687–696.
https://doi.org/10.1182/bloodadvances.2022008628
Published: 2023
Includes: Supplemental data
Journal Articles

Prediction of outcomes after second-line treatment for acute graft-versus-host disease

Phuong Vo, Ted A. Gooley, Paul A. Carpenter, Mohamed L. Sorror, Margaret L. MacMillan, Todd E. DeFor, Paul J. Martin
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3220–3229.
https://doi.org/10.1182/bloodadvances.2021006220
Published: 2022
Journal Articles

HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Kattria van der Ploeg, Jean-Benoît Le Luduec, Philip A. Stevenson, Soo Park, Ted A. Gooley, Effie W. Petersdorf, Brian C. Shaffer, Katharine C. Hsu
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4955–4964.
https://doi.org/10.1182/bloodadvances.2020002086
Published: 2020
Includes: Supplemental data